• Facebook
  • X
  • Instagram
MYELOMA360
  • Home
  • Myinsights
  • MYBoard
  • Strategy & Consulting
Select Page

ASCO 2025: Adding Carboplatin Did Not Result in Statistically Significant Improvements in Patients With TNBC

by MM360 Staff | Jun 4, 2025 | Myeloma News

Source: Pharmacy Times articles New research finds that adding carboplatin to paclitaxel and adjuvant chemotherapy shows no significant survival benefits in triple-negative breast cancer (TNBC). Read More

Maximizing Your Pharmacy Fellowship Experience: Tips for Success

by MM360 Staff | Jun 4, 2025 | Myeloma News

Source: Pharmacy Times articles Establishing a strong foundation and effective networking strategies and pursuing opportunities are key. Read More

ASCO 2025 Delivers Insights into Future of Myelofibrosis Care

by MM360 Staff | Jun 3, 2025 | Myeloma News

Source: Pharmacy Times articles Explore the latest advancements in myelofibrosis treatment, focusing on JAK inhibitors and pegylated interferons for improved patient outcomes. Read More

S2. Ep 56: Insights from a Pharmacy Times Peer Exchange: How to Talk the Talk

by MM360 Staff | Jun 3, 2025 | Myeloma News

Source: Pharmacy Times articles Experts share insights on patient discussions and side effect management strategies in HER2 breast cancer. Read More

Expert Q&A: Pharmacist-Led Strategies to Improve Cholesterol Management

by MM360 Staff | Jun 3, 2025 | Myeloma News

Source: Pharmacy Times articles Amanda Gronniger, PharmD, CPh, BCCP discusses practical strategies pharmacists can use to improve cholesterol management, from lifestyle counseling to emerging therapies. Read More

Camber Pharmaceuticals Announces Addition of Olmesartan Medoxomil Tablets, USP

by MM360 Staff | Jun 3, 2025 | Myeloma News

Source: Pharmacy Times articles Post Content Read More
« Older Entries
Next Entries »

Recent Content

  • Rilonacept in Recurrent Pericarditis: Mechanism of Action, Patient Management, and Clinical Considerations
  • Zyprexa Added to Standard Antiemetics Reduces Nausea, Vomiting in Radiation
  • Op-Ed: Expand Patient Choice to Lower Medication Costs
  • Sasanlimab-BCG Combo May Delay Recurrence in Bladder Cancer
  • Meta-Analysis Evaluates RSV Viral Load and Symptom Kinetics
  • Personalized Vaccine Elicits Responses in Patients With Kidney Cancer
  • SCIg More Effective Immunoglobulin Option for Immunocompromised Patients With Inborn Errors of Immunity
  • GLP-1 Receptor Agonists Demonstrate Increased Risk of Neovascular Age-Related Macular Degeneration in Diabetes
  • The Invisibility of Blood Cancers to Others
  • Op-Ed: Prescribing Cascade Is Avoidable—If We Empower Pharmacists to Intervene
  • Facebook
  • X
  • Instagram
©2016-2025 MYELOMA360 & Connect BioMed
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
SettingsAccept
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT